Page 21 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 21

xx      Introduction


         advance veterinary-based practice and inform future human clini-   14.   The elucidation of the canine genome and its resemblance
         cal trials that may follow. Some of the aspects of companion ani-  and relevance to the human genome open unique and unpar-
                                                                   alleled opportunities to study comparative oncology from a
         mal cancer that enable attractive comparative models include the
  VetBooks.ir  following:                                         Clients who seek treatment for their companion animals with
                                                                                  9
                                                                   genetic perspective.
           1.   Companion dogs and cats are genetically outbred (like hu-
             mans), as opposed to many experimental models of rodents   cancer are a devoted and compassionate subset of the population.
             and other animals.                                Working with these caregivers can be a very satisfying aspect of a
           2.   The cancers seen in practice are spontaneously developing as   frequently frustrating specialty. Clients are almost always satisfied
             opposed to experimentally induced and better recapitulate   with an honest and aggressive attempt to cure, control, or palliate
             the natural human and veterinary condition.       the disease of their companion, making the experience satisfying
           3.   Companion species share the same environment as their   for the veterinarian, for the client, and, most important, for the
             caregivers and may serve as epidemiologic or etiologic senti-  companion.
             nels for the changing patterns of cancer development seen in   Oncology also offers the inquisitive veterinarian a complex and
             humans.                                           challenging area for both clinical and basic research. The challenges
           4.   Companion species have a higher incidence of some cancers   and accomplishments in oncology have been and continue to be
             (e.g., osteosarcoma, non-Hodgkin lymphoma) than humans.  very impressive. Oncology offers unlimited opportunity for the
           5.   Most animal cancers will progress at a more rapid rate than   pursuit of knowledge for the benefit of animals and humankind.
             will the human counterparts. This permits more rapid and   “Cancer, unlike politics and religion, is not a topic of controversy.
             less costly outcome determinations such as time to metasta-  No one is for it. Cancer is not another word for death. Neither is it
             sis, local recurrence, and survival.              a single disease for which there is one cure. Instead, it takes many
           6.   Because fewer established “gold standard” treatments exist in   forms, and each form responds differently to treatment”. 10
             veterinary medicine compared with human medicine, it is   Clinical and comparative oncology continues to be a rapidly
             ethically acceptable to attempt new forms of therapy on an   advancing field of study. More training programs are developed
             untreated cancer rather than wait to initiate new treatments   each year that allow a wider distribution of experienced veterinar-
             until all “known” treatments have failed, as is common in   ians into practice, research, industry, government, and the aca-
             the human condition. It is important to recognize that this   demic setting. Through the continued investigation of tumor
             latitude in clinical trials can be misused to permit diverse   biology and treatment and the inclusion of veterinary species in
             and poorly characterized or even unethical treatments to be   well-designed, rigorous, and humane clinical trials, the veterinary
             attempted as well. We have an obligation to ensure that our   profession will play a key role in advancing the diagnosis, treat-
             patients are not denied known effective treatment while at   ment, and prevention of cancer for all species.
             the same time planning well-designed prospective clinical tri-
             als of newer, scientifically sound treatment methods.  David M. Vail, Douglas H. Thamm, and Julius M. Liptak
           7.   Companion species’ cancers are more akin to human cancers
             than are rodent tumors in terms of patient size and cell kinet-  References
             ics. Dogs and cats also share similar characteristics of physi-
             ology  and  metabolism  for  most  organ  systems  and  drugs.     1.   American Pet Products Association 2011-2012 National Pet Owners Survey.
             Such correspondence allows better and safer comparison of   http://www.americanpetproducts.org/press_industrytrends.asp.  Accessed
                                                                   December 28, 2011.
             treatment modalities such as surgery, radiation, and chemo-    2.   Dorn CR: Epidemiology of canine and feline tumors, Compend Contin Educ
             therapy between animals and humans to be made.        Pract Vet 12:307–312, 1976.
           8.   Dogs and cats have intact immune systems as opposed to     3.   Animal Health Survey: In Companion animal news, Englewood, CO, 1998,
             many  rodent  model  systems,  which  allows  immunologic   Morris Animal Foundation, 2005.
             assays and treatment approaches to be explored. Further-    4.   Bronson RT: Variation in age at death of dogs of different sexes and breeds,
                                                                   Am J Vet Res 43:2057–2059, 1982.
             more, their cancers develop in a syngeneic tumor microenvi-    5.   Gobar GM, Case JT, Kass PH: Program for surveillance of causes of death of
             ronment and tumor–tumor microenvironment interactions   dogs, using the Internet to survey small animal veterinarians, J Am Vet Med
             are equally important to understand basic tumor biology and   Assoc 213:251–256, 1998.
             the development of novel therapeutic targets.       6.   Hansen K, Khanna C: Spontaneous and genetically engineered animal mod-
                                                                   els: use in preclinical cancer drug development, Eur J Cancer 40:858–880,
           9.   Companion animal trials are generally more economical to   2004.
             perform than human trials.                          7.   Mukherjee S: The emperor of all maladies: a biography of cancer, New York,
          10.   Companion animals live long enough to determine the   2010, Scribner.
             potential late effects of treatment.                8.   LeBlanc AK, Breen M, Choyke P, et al.: Perspectives from man’s best friend:
          11.   Regional referral centers exist to concentrate case accrual and   National Academy of Medicine’s Workshop on Comparative Oncology, Sci
                                                                   Transl Med 8:324ps5, 2016.
             facilitate clinical trials.                         9.   Linblad-Toh K, Wade CM, Mikkelsen TS, et al.: Genome sequence, compar-
          12.   Clients are often willing to allow a necropsy, which is a cru-  ative analysis and haplotype structure of the domestic dog, Nature 438:803–
             cial end point for not only tumor control but also treatment-  819, 2005.
             related toxicity.                                  10.   Mooney  S:  A snowflake in my hand, New  York, 1989, Dell Publishing,
                                                                     Bantam Doubleday.
          13.   Dogs and cats are large enough for high-resolution imaging
             studies and multiple sampling opportunities, as well as for
             surgical interventions.
   16   17   18   19   20   21   22   23   24   25   26